What's a successful failure? Atlas' Booth sounds taps for Merck-backed Quartet Medicine
Atlas Venture sounded taps for biotech startup Quartet Medicine this morning — done in by a troubling tox signal that scuttled its plans to develop a …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.